US Stock MarketDetailed Quotes

FBRX Forte Biosciences

Watchlist
  • 0.559
  • -0.001-0.18%
Close Jun 14 16:00 ET
20.37MMarket Cap-665P/E (TTM)

Forte Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-15.20%30.44M
-9.67%37.13M
-9.67%37.13M
4.85%46.19M
-21.07%30.43M
-10.32%35.9M
-2.25%41.1M
-2.25%41.1M
-3.54%44.05M
-24.11%38.55M
-Cash and cash equivalents
-15.20%30.44M
-70.90%11.96M
-70.90%11.96M
-52.00%21.14M
-46.98%20.44M
-10.32%35.9M
-2.25%41.1M
-2.25%41.1M
-3.54%44.05M
-24.11%38.55M
-Short-term investments
----
--25.16M
--25.16M
--25.04M
--9.99M
----
----
----
----
----
Prepaid assets
217.31%825K
204.11%1.04M
204.11%1.04M
92.74%823K
-5.39%193K
-9.41%260K
-11.89%341K
-11.89%341K
-44.69%427K
-78.46%204K
Other current assets
113.76%233K
135.71%165K
135.71%165K
-21.01%94K
37.23%129K
22.47%109K
-21.35%70K
-21.35%70K
0.00%119K
-32.37%94K
Total current assets
-13.15%31.5M
-7.67%38.33M
-7.67%38.33M
5.62%47.1M
-20.85%30.75M
-10.24%36.27M
-2.37%41.51M
-2.37%41.51M
-4.21%44.59M
-25.12%38.85M
Non current assets
Net PPE
--106K
--109K
--109K
--98K
--30K
----
--0
--0
----
----
-Gross PPE
--124K
--118K
--118K
----
----
----
--0
--0
----
----
-Accumulated depreciation
---18K
---9K
---9K
----
----
----
--0
--0
----
----
Non current prepaid assets
-16.94%353K
3.81%491K
3.81%491K
21.11%631K
-56.33%376K
-51.70%425K
-38.81%473K
-38.81%473K
--521K
--861K
Other non current assets
366.67%56K
307.69%53K
307.69%53K
269.23%48K
138.46%31K
-7.69%12K
0.00%13K
0.00%13K
-98.44%13K
-98.61%13K
Total non current assets
17.85%515K
34.36%653K
34.36%653K
45.51%777K
-50.00%437K
-51.06%437K
-38.17%486K
-38.17%486K
-35.97%534K
-13.12%874K
Total assets
-12.78%32.02M
-7.18%38.98M
-7.18%38.98M
6.10%47.88M
-21.49%31.18M
-11.13%36.71M
-3.02%42M
-3.02%42M
-4.77%45.13M
-24.90%39.72M
Liabilities
Current liabilities
Payables
25.56%1.69M
23.50%1.42M
23.50%1.42M
349.54%5.35M
330.66%3.01M
132.99%1.34M
21.88%1.15M
21.88%1.15M
-48.88%1.19M
-29.14%698K
-accounts payable
25.56%1.69M
23.50%1.42M
23.50%1.42M
349.54%5.35M
330.66%3.01M
132.99%1.34M
21.88%1.15M
21.88%1.15M
-48.88%1.19M
-29.14%698K
Current accrued expenses
-61.25%813K
14.00%1.3M
14.00%1.3M
175.43%1.27M
648.75%2.7M
553.58%2.1M
767.18%1.14M
767.18%1.14M
-28.46%460K
-74.21%361K
Current liabilities
-11.38%3.33M
15.32%3.67M
15.32%3.67M
225.82%7.47M
316.39%6.3M
199.36%3.76M
80.83%3.18M
80.83%3.18M
-38.69%2.29M
-49.19%1.51M
Non current liabilities
Preferred securities outside stock equity
----
----
----
----
----
----
----
----
--0
--0
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-11.38%3.33M
15.32%3.67M
15.32%3.67M
225.82%7.47M
316.39%6.3M
199.36%3.76M
80.83%3.18M
80.83%3.18M
-38.69%2.29M
-49.19%1.51M
Shareholders'equity
Share capital
71.43%36K
71.43%36K
71.43%36K
71.43%36K
40.00%21K
40.00%21K
40.00%21K
40.00%21K
40.00%21K
7.14%15K
-common stock
71.43%36K
71.43%36K
71.43%36K
71.43%36K
40.00%21K
40.00%21K
40.00%21K
40.00%21K
40.00%21K
7.14%15K
Retained earnings
-34.27%-125.94M
-36.16%-118.52M
-36.16%-118.52M
-37.10%-112.65M
-30.38%-102.69M
-23.85%-93.8M
-18.97%-87.04M
-18.97%-87.04M
-17.68%-82.17M
-26.89%-78.77M
Paid-in capital
21.99%154.59M
22.21%153.79M
22.21%153.79M
22.44%153.03M
9.06%127.56M
9.47%126.72M
9.72%125.84M
9.72%125.84M
10.16%124.98M
4.46%116.96M
Gains losses not affecting retained earnings
---2K
--4K
--4K
---5K
--1K
----
--0
--0
----
----
Total stockholders'equity
-12.94%28.69M
-9.03%35.31M
-9.03%35.31M
-5.67%40.41M
-34.87%24.88M
-17.73%32.95M
-6.57%38.82M
-6.57%38.82M
-1.87%42.84M
-23.45%38.21M
Total equity
-12.94%28.69M
-9.03%35.31M
-9.03%35.31M
-5.67%40.41M
-34.87%24.88M
-17.73%32.95M
-6.57%38.82M
-6.57%38.82M
-1.87%42.84M
-23.45%38.21M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -15.20%30.44M-9.67%37.13M-9.67%37.13M4.85%46.19M-21.07%30.43M-10.32%35.9M-2.25%41.1M-2.25%41.1M-3.54%44.05M-24.11%38.55M
-Cash and cash equivalents -15.20%30.44M-70.90%11.96M-70.90%11.96M-52.00%21.14M-46.98%20.44M-10.32%35.9M-2.25%41.1M-2.25%41.1M-3.54%44.05M-24.11%38.55M
-Short-term investments ------25.16M--25.16M--25.04M--9.99M--------------------
Prepaid assets 217.31%825K204.11%1.04M204.11%1.04M92.74%823K-5.39%193K-9.41%260K-11.89%341K-11.89%341K-44.69%427K-78.46%204K
Other current assets 113.76%233K135.71%165K135.71%165K-21.01%94K37.23%129K22.47%109K-21.35%70K-21.35%70K0.00%119K-32.37%94K
Total current assets -13.15%31.5M-7.67%38.33M-7.67%38.33M5.62%47.1M-20.85%30.75M-10.24%36.27M-2.37%41.51M-2.37%41.51M-4.21%44.59M-25.12%38.85M
Non current assets
Net PPE --106K--109K--109K--98K--30K------0--0--------
-Gross PPE --124K--118K--118K--------------0--0--------
-Accumulated depreciation ---18K---9K---9K--------------0--0--------
Non current prepaid assets -16.94%353K3.81%491K3.81%491K21.11%631K-56.33%376K-51.70%425K-38.81%473K-38.81%473K--521K--861K
Other non current assets 366.67%56K307.69%53K307.69%53K269.23%48K138.46%31K-7.69%12K0.00%13K0.00%13K-98.44%13K-98.61%13K
Total non current assets 17.85%515K34.36%653K34.36%653K45.51%777K-50.00%437K-51.06%437K-38.17%486K-38.17%486K-35.97%534K-13.12%874K
Total assets -12.78%32.02M-7.18%38.98M-7.18%38.98M6.10%47.88M-21.49%31.18M-11.13%36.71M-3.02%42M-3.02%42M-4.77%45.13M-24.90%39.72M
Liabilities
Current liabilities
Payables 25.56%1.69M23.50%1.42M23.50%1.42M349.54%5.35M330.66%3.01M132.99%1.34M21.88%1.15M21.88%1.15M-48.88%1.19M-29.14%698K
-accounts payable 25.56%1.69M23.50%1.42M23.50%1.42M349.54%5.35M330.66%3.01M132.99%1.34M21.88%1.15M21.88%1.15M-48.88%1.19M-29.14%698K
Current accrued expenses -61.25%813K14.00%1.3M14.00%1.3M175.43%1.27M648.75%2.7M553.58%2.1M767.18%1.14M767.18%1.14M-28.46%460K-74.21%361K
Current liabilities -11.38%3.33M15.32%3.67M15.32%3.67M225.82%7.47M316.39%6.3M199.36%3.76M80.83%3.18M80.83%3.18M-38.69%2.29M-49.19%1.51M
Non current liabilities
Preferred securities outside stock equity ----------------------------------0--0
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -11.38%3.33M15.32%3.67M15.32%3.67M225.82%7.47M316.39%6.3M199.36%3.76M80.83%3.18M80.83%3.18M-38.69%2.29M-49.19%1.51M
Shareholders'equity
Share capital 71.43%36K71.43%36K71.43%36K71.43%36K40.00%21K40.00%21K40.00%21K40.00%21K40.00%21K7.14%15K
-common stock 71.43%36K71.43%36K71.43%36K71.43%36K40.00%21K40.00%21K40.00%21K40.00%21K40.00%21K7.14%15K
Retained earnings -34.27%-125.94M-36.16%-118.52M-36.16%-118.52M-37.10%-112.65M-30.38%-102.69M-23.85%-93.8M-18.97%-87.04M-18.97%-87.04M-17.68%-82.17M-26.89%-78.77M
Paid-in capital 21.99%154.59M22.21%153.79M22.21%153.79M22.44%153.03M9.06%127.56M9.47%126.72M9.72%125.84M9.72%125.84M10.16%124.98M4.46%116.96M
Gains losses not affecting retained earnings ---2K--4K--4K---5K--1K------0--0--------
Total stockholders'equity -12.94%28.69M-9.03%35.31M-9.03%35.31M-5.67%40.41M-34.87%24.88M-17.73%32.95M-6.57%38.82M-6.57%38.82M-1.87%42.84M-23.45%38.21M
Total equity -12.94%28.69M-9.03%35.31M-9.03%35.31M-5.67%40.41M-34.87%24.88M-17.73%32.95M-6.57%38.82M-6.57%38.82M-1.87%42.84M-23.45%38.21M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg